Market Overview

12 Biggest Mid-Day Gainers For Monday

  • Esperion Therapeutics Inc (NASDAQ: ESPR) shares climbed 49.3 percent to $35.34 after the company reported the FDA confirmation regarding regulatory pathway to approval for an LDL-C lowering indication for bempedoic acid.
  • Bellerophon Therapeutics Inc (NASDAQ: BLPH) shares surged 35.4 percent to $1.39.
  • Nektar Therapeutics (NASDAQ: NKTR) shares jumped 34.2 percent to $20.80 after the company reported that it has achieved primary and secondary endpoints in Phase 3 SUMMIT-07 study.
  • CytomX Therapeutics Inc (NASDAQ: CTMX) climbed 23.5 percent to $18.74. Bristol-Myers Squibb Co (NYSE: BMY) and CytomX Therapeutics disclosed that they have extended worldwide partnership to discover Probody therapeutics for the treatment of cancer and other diseases.
  • Dominion Diamond Corp (NYSE: DDC) shares surged 22.6 percent to $12.16. The Washington Companies proposed to acquire Dominion Diamond for US$13.50 per share in cash.
  • Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares jumped 17.5 percent to $9.05. Aurinia Pharmaceuticals shares have climbed 148.39 percent over the past 52 weeks, while the S&P 500 index has gained 15.92 percent in the same period.
  • ContraVir Pharmaceuticals Inc (NASDAQ: CTRV) shares gained 16.6 percent to $1.69.
  • Omeros Corporation (NASDAQ: OMER) shares surged 11.2 percent to $11.72.
  • FireEye Inc (NASDAQ: FEYE) shares climbed 8.6 percent to $11.65. Bank of America upgraded FireEye from Neutral to Buy.
  • Aralez Pharmaceuticals Inc (NASDAQ: ARLZ) gained 7.1 percent to $2.41 after the company disclosed that its CEO has purchased 500,000 open market shares at an average price of $2.46 per share.
  • American Railcar Industries, Inc. (NASDAQ: ARII) rose 7.1 percent to $42.71. Cowen & Co. upgraded American Railcar from Market Perform to Outperform.
  • MeetMe Inc (NASDAQ: MEET) shares surged 4.8 percent to $5.44. Canaccord Genuity initiated coverage on MeetMe with a Buy rating.

Latest Ratings for ESPR

Mar 2019JP MorganUpgradesUnderweightNeutral
Dec 2018Goldman SachsInitiates Coverage OnSell
Oct 2018BTIG ResearchInitiates Coverage OnBuy

View More Analyst Ratings for ESPR
View the Latest Analyst Ratings

Posted-In: Mid-Day GainersNews Intraday Update Markets Analyst Ratings Movers


Related Articles (ARII + ARLZ)

View Comments and Join the Discussion!

Latest Ratings

VREXNorthland SecuritiesInitiates Coverage On42.0
EAMorgan StanleyMaintains88.0
ELMorgan StanleyMaintains178.0
SPLKMorgan StanleyMaintains140.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Trader Essentials
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Evening Trade Opportunity With Early Morning UK News

Disney's Remake Strategy Is Working To Perfection